Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE2331
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM43095
GPL341
pool of a10, a11, a4 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a10, a11, and a4 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43096
GPL341
pool of a10, a11 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a10 and a11 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43097
GPL341
individual rat a10 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a10 in proestrus. a is RXR treatment, b is control
GSM43098
GPL341
individual rat a11 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a11 in estrus. a is RXR treatment, b is control
GSM43099
GPL341
pool of a12, a14, a7 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a12, a14, and a7 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43100
GPL341
pool of a12, a14 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a12 and a14 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43101
GPL341
individual rat a12 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a12 in estrus. a is RXR treatment, b is control
GSM43102
GPL341
individual rat a14 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a14 in proestrus or estrus. a is RXR treatment, b is control
GSM43103
GPL341
pool of a2, a3, a5 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a2, a3 and a5 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43104
GPL341
pool of a2, a3 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a2 and a3 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43105
GPL341
individual rat a2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a2 in estrus. a is RXR treatment, b is control
GSM43106
GPL341
individual rat a3 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a3 in proestrus or estrus. a is RXR treatment, b is control
GSM43107
GPL341
individual rat a3, technical rep1 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43108
GPL341
individual rat a3, technical rep2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43109
GPL341
pool of a4, a7 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a4 and a7 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43110
GPL341
individual rat a4 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a4 in diestrus. a is RXR treatment, b is control
GSM43111
GPL341
pool of a5, a6 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a5 and a6 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43112
GPL341
individual rat a5 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a5 in diestrus. a is RXR treatment, b is control
GSM43113
GPL341
pool of a6, a8, a9 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a6, a8, and a9 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43114
GPL341
individual rat a6 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a6 in diestrus. a is RXR treatment, b is control
GSM43115
GPL341
individual rat a7 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a7 in diestrus. a is RXR treatment, b is control
GSM43116
GPL341
pool of a8, a9 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a8 and a9 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43117
GPL341
individual rat a8 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a8 in diestrus. a is RXR treatment, b is control
GSM43118
GPL341
individual rat a9 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a9 in diestrus. a is RXR treatment, b is control
GSM43119
GPL341
pool of 12 a-individual rats (aliquot aq) pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43120
GPL341
aliquot aq, technical rep1 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43121
GPL341
aliquot aq, technical rep2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43122
GPL341
aliquot aq, technical rep3 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43123
GPL341
pool of b10, b11, b13 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b10, b11, and b13 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43124
GPL341
pool of b10, b11 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b10 and b11 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43125
GPL341
individual rat b10 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b10 in estrus. a is RXR treatment, b is control
GSM43126
GPL341
individual rat b11 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b11 in diestrus. a is RXR treatment, b is control
GSM43127
GPL341
pool of b12, b14, b15 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b12, b14 and b15 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43128
GPL341
pool of b12, b14 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b12 and b14 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43129
GPL341
individual rat b12 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b12 in diestrus. a is RXR treatment, b is control
GSM43130
GPL341
pool of b13, b15 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b13 and b15 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43131
GPL341
individual rat b13 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b13 in diestrus. a is RXR treatment, b is control
GSM43132
GPL341
individual rat b14 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b14 in diestrus. a is RXR treatment, b is control
GSM43133
GPL341
individual rat b15 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b15 in diestrus. a is RXR treatment, b is control
GSM43134
GPL341
pool of b2, b3, b5 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b2, b3 and b5 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43135
GPL341
pool of b2, b3 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b2 and b3 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43136
GPL341
individual rat b2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b2 in diestrus. a is RXR treatment, b is control
GSM43137
GPL341
individual rat b3 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b3 in estrus. a is RXR treatment, b is control
GSM43138
GPL341
individual rat b3, technical rep1 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43139
GPL341
individual rat b3, technical rep2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43140
GPL341
pool of b5, b6 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b5 and b6 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43141
GPL341
individual rat b5 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b5 in diestrus. a is RXR treatment, b is control
GSM43142
GPL341
pool of b6, b8, b9 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b6, b8 and b9 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43143
GPL341
individual rat b6 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b6 in diestrus. a is RXR treatment, b is control
GSM43144
GPL341
pool of b8, b9 pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b8 and b9 to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43145
GPL341
individual rat b8 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b8 in proestrus or estrus. a is RXR treatment, b is control
GSM43146
GPL341
individual rat b9 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b9 in diestrus. a is RXR treatment, b is control
GSM43147
GPL341
pool of 12 b-individual rats (aliquot bq) pooled mammary glands (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group b to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43148
GPL341
aliquot bq, technical rep1 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group b to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43149
GPL341
aliquot bq, technical rep2 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group b to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
GSM43150
GPL341
aliquot bq, technical rep3 individual rat mammary gland (Female Wistar Furth Rat) total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group b to give a total of 10 mu g of the fragmented cRNA targets. a is RXR treatment, b is control
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes